VC
Value Add VC
⚡HomePulse⚡Helpful Apps📝Blog🤝Partner
Illustration for: SpaceX Stock Rebounds to Near Its $135 IPO Price
Value Add VC/Pulse/IPOFOLLOW-UP

SpaceX Stock Rebounds to Near Its $135 IPO Price

SpaceX shares climbed back to near their $135 IPO price on August 10, recovering from a stretch earlier this month when the stock traded below its offering price for the first time since going public.

By the Numbers

$135/share
IPO price
$225+
Post-IPO high
911.5M shares freed
Aug 6 lockup
Aug 10, 2026
Rebound date
TC
Trace Cohen
Early-stage VC & angel · Founder, New York Venture Partners
August 10, 2026
1 min read
ShareXLinkedInEmail
TC

The VC Read · Trace's Take

Trace Cohen

A round-trip back to IPO price after a lockup-driven dip is the market telling you the sell-off was a supply event, not a valuation reassessment -- that's a meaningfully more bullish read than the headline 'shares fall below IPO price' story a week ago implied. Still, $135 versus a post-IPO peak above $225 is recovery, not euphoria; the next lockup tranche is the number to actually calendar, not this rebound.

Analysis

SpaceX shares climbed back to near their $135 IPO price on August 10, according to CNBC, recovering from a stretch earlier this month when the stock traded below its offering price for the first time since going public. Pulse tracked that slide as it happened: shares had fallen from a post-IPO high above $225 down toward $108, pressured in part by the first major lockup expiration on August 6, which freed roughly 911.5 million shares worth as much as $116 billion for potential sale and more than doubled the stock's public float.

What's changed since then: the stock has recovered roughly the full distance back to its IPO price in a matter of days, suggesting the lockup-driven selling pressure was either smaller in practice than the freed-share total implied, or was absorbed by buyers without moving the price further down. SpaceX also beat expectations in its first earnings report as a public company, which Pulse covered separately, giving the stock a fundamental catalyst independent of the lockup dynamics.

A round-trip back to the IPO price after a lockup-driven dip and a subsequent earnings beat is a meaningfully different story than either the dip or the beat in isolation would suggest. It indicates the market's read on the lockup was a supply-and-demand event rather than a signal about SpaceX's underlying value -- once the initial selling pressure cleared, the stock found its way back to roughly where it started. That said, $135 is still well below the stock's post-IPO peak above $225, and a rebound to the offering price is recovery, not a return to the euphoria that greeted SpaceX's record-breaking $85.7 billion IPO.

ShareXLinkedInEmail

More on

SpaceX →

Reported by CNBC · Analysis by Value Add Pulse.

← Back to Pulse

THE WIRE in your inbox— Tech, startup & VC news with Trace's take. Free, no spam.

Read Next

IPO· Aug 10, 2026

Defense Tech Firm Lyntris Seeks $492M in US IPO

Illustration for: Defense Tech Firm Lyntris Seeks $492M in US IPO
IPOUp to $528M

Defense Tech Firm Lyntris Seeks $492M in US IPO

Lyntris, a defense technology company building battlefield sensing and connectivity systems, filed an amended S-1 to launch an IPO of 24 million shares priced between $19 and $22, seeking up to $528 million on the NYSE under ticker LYNX.

IPO· Aug 9, 2026

VC Exit Liquidity Hit a Record in Q2: 32 Billion-Dollar IPOs

Illustration for: VC Exit Liquidity Hit a Record in Q2: 32 Billion-Dollar IPOs
IPO

VC Exit Liquidity Hit a Record in Q2: 32 Billion-Dollar IPOs

Crunchbase data shows 32 companies went public at valuations above $1 billion in Q2 2026 and 24 more were acquired above $1 billion for a combined $113 billion, the highest quarterly exit totals on record for venture-backed companies.

IPO· Aug 9, 2026

Caris Leads a Wild Week for Recent IPO Stocks

Illustration for: Caris Leads a Wild Week for Recent IPO Stocks
IPO

Caris Leads a Wild Week for Recent IPO Stocks

Caris Life Sciences jumped 21.6% on a beat-and-raise quarter while BillionToOne fell 29.8% despite beating estimates, the sharpest split in the Renaissance IPO Index in weeks.

@Trace_Cohen·t@nyvp.com